DeSimone Joseph A, Ojha Ambrish, Pathak Rolee, Cohn John
Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Clin Infect Dis. 2004 Nov 15;39(10):e110-2. doi: 10.1086/425502. Epub 2004 Oct 26.
We report a case of successful, rapid desensitization to enfuvirtide after a hypersensitivity reaction in a man with highly drug-resistant human immunodeficiency virus type 1 infection. The patient was desensitized in a monitored intensive care unit and tolerated the rapid desensitization protocol without any serious adverse effects. This case illustrates the ability to safely desensitize patients with limited treatment options who require enfuvirtide therapy.